Biosynthetic novelty index reveals the metabolic potential of rare actinobacteria isolated from highly oligotrophic sediments

Calculations predict that testing of 5 000–10 000 molecules and >1 billion US dollars (£0.8 billion, £1=$1.2) are required for one single drug to come to the market. A solution to this problem is to establish more efficient protocols that reduce the high rate of re-isolation and continuous redisc...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Salazar, Luz A., Quezada, Michelle, Rodríguez-Orduña, Lorena, Ramos-Aboites, Hilda, Capon, Robert J., Souza-Saldívar, Valeria, Barona-Gomez, Francisco, Licona-Cassani, Cuauhtémoc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973853/
https://www.ncbi.nlm.nih.gov/pubmed/36748531
http://dx.doi.org/10.1099/mgen.0.000921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973853/
https://www.ncbi.nlm.nih.gov/pubmed/36748531
http://dx.doi.org/10.1099/mgen.0.000921

Ejemplares similares